← Ivanesemab
What podcasts say about Ivanesemab
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Ivanesemab
1 statement · 1 negative
The FDA rejected Summit’s ibanesimab application after warning that survival benefit was needed.
“the FDA told Summit that without a survival benefit, you shouldn't file this drug for approval. Summit did that anyway, didn't listen to the FDA, filed the drug, and lo and behold, we found out over the weekend that the FDA rejected it.”
Open the episode · 422: FDA's search for a new leader, and China's largest drugmakersListen at 10:35
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.